2022 American Transplant Congress

Tuesday, June 7, 2022

7:00pm-8:00pm

The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5

M. Nayebpour¹, N. Koizumi¹, J. Melancon², M. Hasan²

Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hynes Halls C & D

7:00pm-8:00pm

The Successful Use of De Novo Belatacept with Reduced Dose Tacrolimus to Mitigate the Risks of Delayed Graft Function in Kidney Transplantation

E. Siskind¹, J. Splinter¹, C. Taing¹, A. Adekile², S. Njim¹, S. Shah¹, R. Plews³, D. Conti⁴, S. Patel²

Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hynes Halls C & D

7:00pm-8:00pm

Third Dose of SARS-CoV-2 mRNA Vaccines Significantly Increases Delta (B.1.617.2) Variant Anti-Spike Antibody Levels in Kidney Transplant Recipients

A. Al Jurdi¹, R. B. Gassen¹, T. Borges¹, I. T. Lape¹, L. Morena¹, O. Efe¹, Z. Solhjou², R. El Fekih², C. Kotton¹, J. Azzi², L. Riella¹

All Infections (Excluding Kidney & Viral Hepatitis) IV  •  Hynes Halls C & D

7:00pm-8:00pm

Transplant Graft TMA Injury Post COVID-19 Vaccination

O. Sogbein, A. Rizvi, M. Mujtaba, S. Hussain

Kidney Complications: Non-Immune Mediated Late Graft Failure  •  Hynes Halls C & D

7:00pm-8:00pm

Transplant Patients Risk for SARS-CoV-2 Infection Post-2nd Vaccine Dose; We Are Not Home and Dry Yet

G. Koimtzis¹, L. Szabó¹, P. Nagaraja¹, C. Chalklin¹, D. Elker², A. Asderakis¹

All Infections (Excluding Kidney & Viral Hepatitis) IV  •  Hynes Halls C & D

7:00pm-8:00pm

Transplantation of Hepatitis C Viremic Donor Organs to Hepatitis C Nonviremic Recipients: A Retrospective Review

M. Leick, M. Blaha, M. Henry

Non-Organ Specific: Viral Hepatitis  •  Hynes Halls C & D

7:00pm-8:00pm

Treading the Paradigm Shift: A Single Center Comparative Study of Outcomes Between Pre-Emptive and Early Kidney Transplant with Non Pre-Emptive Kidney Transplant Recipients Innational Kidney and Transplant Institute

E. U. Go, L. Baloloy

Kidney Living Donor: Selection  •  Hynes Halls C & D

7:00pm-8:00pm

Trends in Donor Derived Cell Free DNA Before and After Cellular and Antibody Mediated Rejection

K. Guo¹, J. Friedewald¹, C. Rebello¹, B. Kinsella¹, S. Park², L. Zhao¹

Biomarkers: Clinical Outcomes  •  Hynes Halls C & D

7:00pm-8:00pm

Triple-Knockout Pig Red Blood Cells as Potential Sources for Blood Transfusion in Alloimmunized Patients with Sickle Cell Disease

T. Yamamoto¹, M. H. Bikhet², H. Q. Nguyen², Y. Cui², M. Javed², S. S. Raza², D. Ayares³, H. Iwase², H. Hara², D. K. Cooper¹

Xenotransplantation  •  Hynes Halls C & D

7:00pm-8:00pm

Twelve Month Outcomes of Kidney Transplantation from Hepatitis C Viremic Deceased Donors to Aviremic Recipients

L. A. Binari, R. C. Forbes, S. Rega, I. D. Feurer, A. Dreher, S. Shawar, H. Schaefer, D. Shaffer, B. P. Concepcion

Non-Organ Specific: Viral Hepatitis  •  Hynes Halls C & D